ml 7 has been researched along with Reperfusion Injury in 2 studies
ML-7 : An N-sulfonyldiazepane resullting from the formal condensation of 5-iodo-1-naphthylsulfonic acid with one of the nitrogens of 1,4-diazepane. It is a selective inhibitor of myosin light chain kinase (EC 2.7.11.18).
Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zhang, HF | 1 |
Li, TB | 1 |
Liu, B | 1 |
Lou, Z | 1 |
Zhang, JJ | 1 |
Peng, JJ | 1 |
Zhang, XJ | 1 |
Ma, QL | 1 |
Peng, J | 1 |
Luo, XJ | 1 |
Lin, HB | 1 |
Cadete, VJ | 1 |
Sawicka, J | 1 |
Wozniak, M | 1 |
Sawicki, G | 1 |
2 other studies available for ml 7 and Reperfusion Injury
Article | Year |
---|---|
Inhibition of myosin light chain kinase reduces NADPH oxidase-mediated oxidative injury in rat brain following cerebral ischemia/reperfusion.
Topics: Animals; Azepines; Brain; Brain Ischemia; Disease Models, Animal; Hydrogen Peroxide; Male; Membrane | 2015 |
Effect of the myosin light chain kinase inhibitor ML-7 on the proteome of hearts subjected to ischemia-reperfusion injury.
Topics: Animals; Azepines; Biomechanical Phenomena; Cardiotonic Agents; Electrophoresis, Gel, Two-Dimensiona | 2012 |